PinkDX to Develop Diagnostics that Address Women’s Unmet Medical Needs
PinkDx, an early-stage company focused on positively impacting the health of women, launched with $40 million in Series A financing.
PinkDx, an early-stage company focused on positively impacting the health of women, launched with $40 million in Series A financing.
Scientists combined machine learning with info on blood metabolites to develop a new test able to detect ovarian cancer with 93% accuracy.
Machine learning algorithms designed to diagnose a common infection that affects women showed a diagnostic bias among ethnic groups.
A new study shows that prenatal diagnosis is associated with earlier surgery for babies with congenital heart defects.
Read MoreResearchers have developed a biosensor that could someday help identify those most at risk for osteoporosis using less than a drop of blood.
Read MoreNow a study has found a noninvasive test that could identify women at risk for pelvic floor disorders and improve treatment.
Read MoreKindlabs offers a verticalized genetic testing platform, from wet lab chemistry to software and bioinformatics.
Read MoreRegular health screenings don’t include iron tests also called ferritin tests, the lead author of the study says.
Read MoreThe enhancement of women’s health is a focal point for many companies, and is projected to reach $75.1 billion by 2025.
Read MoreA combination of mass spectrometry and imaging flow cytometry was used to find intact sperm in infertile men.
Read MoreThe test can be used between 23 and 35 weeks of pregnancy to predict development of severe preeclampsia among women who have symptoms of, or have been diagnosed with, hypertension during pregnancy.
Read MoreAnti-mullerian hormone (AMH) is commonly used as a marker to assess ovarian reserve and reproductive potential.
Read MoreThe Peekaboo Click test will enable expecting parents to discover their baby’s gender very early in pregnancy from a simple blood sample, with results returned from the lab as soon as the same day.
Read MoreA new study Journal of Molecular and Cellular Cardiology Plus demonstrates how RNA biomarkers may be used to confirm heart disease.
Read MoreBD received FDA clearance for a comprehensive diagnostic test that directly detects the three most common infectious causes of vaginitis.
Read MoreDevyser Compact is a rapid genetic test for prenatal chromosome testing and is approved under the new more comprehensive regulation.
Read MoreWomen who developed mood and anxiety disorders related to pregnancy and childbirth had altered proteins circulating in their bloodstream.
Read MoreProov, a diagnostics company offering medical grade home tests, received a patent issue notification for its fourth utility patent.
Read More